Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Q4 2024 Innospec Inc Earnings Call

In This Article:

Participants

David Jones; Senior Vice President, Chief Compliance Officer, General Counsel, Company Secretary; Innospec Inc

Patrick Williams; President, Chief Executive Officer, Director; Innospec Inc

Ian Cleminson; Chief Financial Officer, Executive Vice President; Innospec Inc

Jonathan Tanwanteng; Analyst; CJS Securities, Inc.

Presentation

David Jones

Thank you. Welcome to Innospec's earnings call. This is David Jones, I'm Innospec's General Counsel and Chief Compliance Officer.
Earnings release for this presentation is posted on the company's website. During this call, we will make forward-looking statements, which are predictions about future events. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from the anticipated results implied by such forward-looking statements. The risks and uncertainties are detailed in Innospec's 10-K, 10-Q, and other filings with the SEC. Please see the SEC site and Innospec's site for these and related documents.
In today's presentation, we have also included non-GAAP financial measures. A reconciliation to the most directly comparable GAAP financial measure is contained in the earnings release. The non-GAAP financial measures should not be considered as a substitute for or superior to those prepared in accordance with GAAP. They are included as additional items to aid investors understanding of the company's performance in addition to the impact of these items had on financial results.
With me today from Innospec are Patrick Williams, President and Chief Executive Officer; and Ian Cleminson, Executive Vice President and Chief Financial Officer.
And with that, I'll turn it over to you, Patrick.

Patrick Williams

Thank you, David, and welcome, everyone to Innospec's fourth quarter and full-year 2024 conference call.
This was another good quarter for Innospec as we exceeded earnings expectations despite the reduced Oilfield Services activity in Latin America.
In Performance Chemicals, we delivered double-digit operating income growth over the fourth quarter last year, driven by improved sales and margins. We have a balanced pipeline of growth opportunities across our global personal care, home care, agriculture, construction, and other industrial markets.
In addition, the integration and performance of our recent QGP acquisition in Brazil is proceeding to plan and is supporting not only Performance Chemicals but also Fuel Specialties growth opportunities in the region.
Moving to 2025, we continue to target operating income and margin improvement to levels consistent with full year 2022. In Fuel Specialties, operating income increased 7% over the same quarter last year, and operating margin improved to just below our target of 19% to 21%. We remain focused on further margin improvement in parallel with top line growth.
With our industry-leading innovation and customer service capabilities, we are well positioned to continue advancing our global customers' initiatives. Our technology will continue to focus on cleaner fuels, lowering emissions, and improving efficiency in traditional, renewable, and non-fuel applications.
In Oilfield Services as expected, results were similar to the third quarter, with no recovery in Latin America production chemical activity. We currently do not expect this activity to resume in the near term. In 2025, we remain focused on continuing to drive sequential quarterly improvements in our core businesses, including US completions and production, DRA, and the Middle East.
Now I will turn the call over to Ian Clemson, who will review our financial results in more detail, then I will return with some concluding comments. After that, Ian, I will take your questions. Ian?